All News

2017

June

Media Release / Jun 28, 2017

Sandoz signs development and license agreement with Vectura for a US inhaled generic (VR2081)

Read More
Media Release / Jun 15, 2017

FDA accepts Sandoz regulatory submission for a generic version of Advair Diskus®

Read More
Media Release / Jun 12, 2017

Sandoz launches authorized generic version of Pataday® 0.2% ophthalmic solution

Read More

May

Media Release / May 08, 2017

Sandoz and DURECT to develop and market investigational non-opioid analgesic in the US

Read More

March

El Salvador Family
Featured News / Mar 23, 2017

The New Americares-Sandoz Partnership Provides Even More Access to Medicines

Sandoz announced a commitment of $10 million USD in medicines to Americares.

Read More
Media Release / Mar 06, 2017

New data demonstrate Sandoz proposed biosimilar adalimumab has equivalent efficacy to reference medicine

Read More

January

Media Release / Jan 04, 2017

Sandoz launches generic version of Emend® capsules

Read More
2016

December

Media Release / Dec 15, 2016

Sandoz acquires consumer skin care brand AmLactin®

Read More
Media Release / Dec 07, 2016

Sandoz launches generic version of Latisse®

Read More
Media Release / Dec 05, 2016

New interim data demonstrate Sandoz proposed biosimilar rituximab has equivalent efficacy to reference product

Read More

Pages